Preclinical studies indicate that NNMT knockdown or inhibition can protect against diet-induced weight gain and improve metabolic parameters without reducing food intake [8] [9]
If you experience any suspected side effects from a medicine including medicines obtained in a trial report them via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk
Lyzenga-Dean, "One study reported that 50% of patients taking GLP-1 agonists experienced nausea while taking them." The Rebound Effect Discontinuing GLP-1 medications often leads to weight regain
This includes 6% of adults who say they are currently taking one of these drugs, which include Ozempic, Wegovy and MounjaroThe shares of adults who report ever taking these drugs is highest among people with diabetes (43%), followed by those with heart disease (26%) and those who have obesity or overweight (22%), the poll finds
Reduced Inflammation & Pain Certain peptides work by reducing pro-inflammatory markers and cytokines
SGLT2, Sodium-glucose co-transporter-2